Table 2 In vitro antimicrobial susceptibility results for A. baumannii isolates (N = 111)
Antibiotics | Isolates (n) | Resistant n (%) | Sensitive n (%) | Intermediate n (%) |
|---|---|---|---|---|
Colistin | 111 | 0 (0) | 111 (100) | 0 (0) |
Tigecycline | 111 | 0 (0) | 111 (100) | 0 (0) |
Trimethoprim/sulfamethoxazole | 111 | 52 (46.8) | 57 (51.4) | 2 (1.8) |
Minocycline | 111 | 97 (87.4) | 10 (9) | 4 (3.6) |
Gentamicin | 110* | 100 (90.9) | 10 (9.1) | 0 (0) |
Ciprofloxacin | 111 | 104 (93.7) | 7 (6.3) | 0 (0) |
Piperacillin/tazobactam | 110* | 104 (94.5) | 6 (5.5) | 0 (0) |
Amikacin | 111 | 105 (94.6) | 6 (5.4) | 0 (0) |
Cefepime | 111 | 105 (94.6) | 6 (5.4) | 0 (0) |
Imipenem/cilastatin | 111 | 105 (94.6) | 6 (5.4) | 0 (0) |
Meropenem | 111 | 105 (94.6) | 6 (5.4) | 0 (0) |
Ceftazidime | 111 | 106 (95.5) | 4 (3.6) | 1 (0.9) |
Doxycycline | 111 | 106 (96.4) | 4 (3.6) | 0 (0) |
Ampicillin/sulbactam | 111 | 107 (96.4) | 4 (3.6) | 0 (0) |
Aztreonam | 111 | 107 (96.4) | 4 (3.6) | 0 (0) |